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Although the vaccinia virus DNA polymerase is inherently distributive, a highly processive form of the
enzyme exists within the cytoplasm of infected cells (W. F. McDonald, N. Klemperer, and P. Traktman,
Virology 234:168–175, 1997). In the accompanying report we outline the purification of the 49-kDa A20 protein
as a stoichiometric component of the processive polymerase complex (N. Klemperer, W. McDonald, K. Boyle,
B. Unger, and P. Traktman, J. Virol. 75:12298–12307, 2001). To complement this biochemical analysis, we
undertook a genetic approach to the analysis of the structure and function of the A20 protein. Here we report
the application of clustered charge-to-alanine mutagenesis of the A20 gene. Eight mutant viruses containing
altered A20 alleles were isolated using this approach; two of these, tsA20-6 and tsA20-ER5, have tight temper-
ature-sensitive phenotypes. At the nonpermissive temperature, neither virus forms macroscopic plaques and
the yield of infectious virus is <1% of that obtained at the permissive temperature. Both viruses show a
profound defect in the accumulation of viral DNA at the nonpermissive temperature, although both the A20
protein and DNA polymerase accumulate to wild-type levels. Cytoplasmic extracts prepared from cells infected
with the tsA20 viruses show a defect in processive polymerase activity; they are unable to direct the formation
of RFII product using a singly primed M13 template. In sum, these data indicate that the A20 protein plays
an essential role in the viral life cycle and that viruses with A20 lesions exhibit a DNA phenotype that is
correlated with a loss in processive polymerase activity as assayed in vitro. The vaccinia virus A20 protein can,
therefore, be considered a new member of the family of proteins (E9, B1, D4, and D5) with essential roles in
vaccinia virus DNA replication.
Vaccinia virus, the prototypic member of the poxvirus fam-
ily, displays a great deal of genetic and physical autonomy from
the host. The virus replicates solely within the cytoplasm of the
host, and the 192-kb genome is thought to encode most if not
all of the functions required for genome replication, gene ex-
pression, and virion morphogenesis. The centerpiece of the
replication apparatus is the E9 DNA polymerase, which dis-
plays significant homology to the  and  families of eucaryotic
replicative polymerases as well as the polymerases encoded by
herpesviruses. We and others have characterized the polymer-
ase both genetically and biochemically (4, 5,9, 10, 12, 29–31, 36,
38, 39, 41). Temperature-sensitive (ts) alleles, mutator and
anti-mutator alleles, and mutants conferring resistance to
aphidicolin, phosphonoacetic acid, and cytosine arabinoside
have been isolated and studied. The polymerase has been over-
expressed and purified and shown to have both polymerase and
proofreading exonuclease activities. We have also shown that
the enzyme is inherently distributive in vitro, being able to
catalyze the addition of 10 nucleotides (nt) per binding event
when moderate levels of salt (40 mM NaCl) or divalent cations
(8 mM MgCl2) are present (31). In sharp contrast, the cyto-
plasmic lysates of infected cells are able to catalyze the addi-
tion of as many as 7,000 nt in a single binding event under the
same reaction conditions (29). We demonstrated that the pro-
tein(s) responsible for conferring processivity on the viral poly-
merase was present in extracts prepared from infected cells in
which only early proteins were present but not in extracts
prepared from uninfected cells. We also demonstrated that the
vaccinia virus processivity factor had a native molecular mass
of 45 kDa. In the accompanying paper, we describe our iden-
tification of the A20 protein as a stoichiometric component of
the processive form of the polymerase. We show that A20 and
DNA polymerase copurify through six chromatographic steps,
that their physical interaction can be confirmed by coimmuno-
precipitation, and that overexpression of both A20 and DNA
polymerase leads to a corresponding increase in the levels of
processive polymerase activity (24).
In this report, we describe a genetic analysis of A20 aimed at
furthering our understanding of the structure of this protein
and its role(s) in vivo. The use of conditionally lethal mutants
as genetic tools for the study of vaccinia virus has been well
established (8). Four complementation groups of ts mutants
exhibiting a DNA phenotype have been described; these con-
tain lesions in the E9 DNA polymerase, the D5 DNA-inde-
pendent nucleoside triphosphatase (NTPase), the B1 protein
kinase, and the D4 uracil DNA glycosylase (16, 17, 33, 34, 36,
37, 41). Other proteins implicated in genome replication have
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been identified biochemically or by sequence analysis. These
include the I3 single-strand DNA binding protein (SSB), the
H6 topoisomerase, the A50 DNA ligase, the F2 dUTPase, the
J3 thymidine kinase, the A48 thymidylate kinase, the F4:I4
ribonucleotide reductase, and the A22 resolvase (19, 40). The
roles played by some of the latter group have been character-
ized using drug-resistant mutants, deletion mutants, or induc-
ible recombinants.
Unfortunately, no mutants with lesions in the A20 gene were
isolated in the initial mutant collections prepared by the Con-
dit and Ensinger laboratories (6, 7, 13, 14). We therefore
undertook a reverse genetic approach and subjected the A20
gene to targeted mutagenesis in an attempt to isolate a condi-
tionally lethal allele. These efforts were successful, and we
report here that the phenotype of the ts mutants we generated
confirms that the A20 protein plays an essential role in viral
DNA replication and that its disruption compromises the pro-
duction of processive DNA polymerase activity.
(A preliminary report of this work was presented at the
XIIIth International Poxvirus Workshop, Montpellier, France,
September 2000.)
MATERIALS AND METHODS
Materials. Restriction endonucleases, Taq DNA polymerase, T4 DNA ligase,
calf intestinal phosphatase, pancreatic RNase, Escherichia coli DNA polymerase
I, and DNA molecular weight standards were purchased from either Roche
Molecular Biochemicals (Indianapolis, Ind.) or New England Biolabs, Inc. (Bev-
erly, Mass.) and used as specified by the manufacturer. DNase I was obtained
from Cooper Biochemicals, Inc. (West Chester, Pa.). [35S]methionine, 32P-la-
beled nucleoside triphosphates (NTPs), and [methyl-3H]thymidine were pur-
chased from New England Nuclear Corporation (Boston, Mass.). Lipofectamine
Plus, Geneticin (G418 sulfate), and 14C-labeled protein molecular weight mark-
ers were acquired from GIBCO-BRL Life Technologies (Gaithersburg, Md.)
and used as specified.
Cells and viruses. BSC40 African green monkey kidney cells and mouse L cells
were maintained as monolayer cultures in Dulbecco modified Eagle medium
(DMEM) (GIBCO-BRL, Gaithersburg, Md.) containing 5% fetal calf serum.
Viral stocks of wild-type (wt) vaccinia virus (strain WR), ts42, ts17, and ts2 and
the A20 mutants described below were prepared by ultracentrifugation of in-
fected cytoplasmic extracts through a 36% sucrose cushion. Titers of all viral
stocks were obtained by plaque assays performed on BSC40 cells. The permissive
and nonpermissive temperatures for analysis of ts mutants were 31.5 and 40°C,
respectively.
Mutagenesis and cloning of the vaccinia virus A20 gene. Clustered charge-to-
alanine mutagenesis was performed on multiple regions of the vaccinia virus A20
gene as summarized in Fig. 1. Mutations were introduced by overlap PCR (11).
To construct each allele, two sets of primer pairs were used to amplify the
targeted region: (i) an upstream 5 primer (UN) and a 3 primer which introduces
the complement of the mutation (A20-XUP) and (ii) a 5 primer which intro-
duces the mutation (A20-XDN) and a downstream 3 primer (DN). Both UN and
DN contain BamHI sites at their 5 termini. PCRs performed with these primer
pairs and the WR genome as a template yielded products that overlapped by 17
nt. A mixture of these products then served as the template for a second round
of PCR performed with corresponding upstream 5 (UN) and downstream 3
(DN) primers. The final product was gel purified, digested with BamHI, and
cloned into pUC/neo, a plasmid containing the neomycin resistance gene under
the control of the vaccinia virus P7.5 constitutive promoter (42). All constructs
were subjected to DNA sequence analysis to confirm the insertion of the engi-
neered mutations and the absence of spurious mutations. The primers used were
as follows (the nucleotides changed to direct the alanine substitutions are bold-
faced, and the BamHI sites used for cloning are underlined): A20-1, (i) UA (5
ATGGATCCAGTCTATCATCGACAC 3) and A20-1UP (5 TTTGCTACCG
CAGCATAATAATCAGATATTGACG 3), (ii) A20-1DN (5 TATGCTGCG
GTAGCAAATAAACCGTTTAATAT 3) and DA (5 GCGGATCCAATATA
CATGAACGAG 3); A20-2, (i) UA and A20-2UP (5 ACTTGCCATAGCAG
CTGGTATTTGAAAAGAGT 3), (ii) A20-2DN (5 CAGCTGCTATGGCAA
GTGCGTGTAACAAAGT 3) and DA; A20-3, (i) UB (5 ATGGATCCGAGA
CGTCAATATCTG 3) and A20-3UP (5 ATGTGGCTGCCGCTATTTCAAT
TTCTAAAT 3), (ii) A20-3DN (5 AATAGCGGCAGCCACATTATTTGACG
ACGA 3) and DB (5 TAGGATCCTCGTCCTATAGTGTCT 3); A20-4, (i)
UB and A20-4UP (5 ATAACGCGGCGGCAAATAATGTGTCTTCCT 3), (ii)
A20-4DN (5 ATTTGCCGCCGCGTTATACTCTATTATAGAACG 3) and
DB; A20-ER, (i) UB and A20-ERUP (5 AAAGAGGCTGCTATAATAGAGT
ATAACT 3), (ii) A20-ERDN (5 ATTATAGCAGCCTCTTTTGATGATAA
ATT 3) and DB; A20-5, (i) UB and A20-5UP (5 GAAATGCAGCAGCAAA
AGAGCGTTCTATAA 3), (ii) A20-5DN (5 TTTTGCTGCTGCATTTCCAA
AAATATCCAT 3) and DB; A20-5ER, (i) UB and A20-5ERUP (5
TGCAGCAGCAAAAGAGGCTGCTATAATAGAGTATAACT 3), (ii) A20-
5ERDN (5 ATTATAGCAGCCTCTTTTGCTGCTGCATTTCCAAAAATAT
CCAT 3) and DB; A20-6, (i) UC (5 CAGGATCCTAGTGAGTACGGATTA
3) and A20-6UP (5 TTGCCGCTGCTACTGCTACAAATGTATGTTCTC 3),
(ii) A20-6DN (5 AGCAGTAGCAGCGGCAAACACATTTTCCATTTT 3)
and DC (5 TAGGATCCAATACCCTAACGGAG 3); A20-7, (i) UC and A20-
7UP (5 TTATTGCTGCTGCTACAGTTCCGGATTTAT 3), (ii) A20-7DN (5
TGTAGCAGCAGCAATAAAAAACCAATCAGC 3) and DC; A20-8, (i) UC
and A20-8UP (5 TTTGCTATTGCTGCTGCTACAGTTCCGGATTTAT 3),
(ii) A20-8DN (5 AGCAGCAGCAATAGCAAACCAATCAGCATTTGA 3)
and DC.
Transient dominant selection and isolation of mutants. The endogenous A20
allele in the viral genome was replaced with the mutant A20 alleles by transient
dominant selection. Dishes (diameter, 35 mm) of BSC40 cells were infected with
FIG. 1. Clustered charge-to-alanine mutagenesis of the vaccinia virus (strain WR) A20R gene. Altered alleles of A20R encoding proteins in
which the highlighted charged residues were changed to alanine were generated as described in Materials and Methods. The endogenous A20 allele
was then replaced with the mutant allele through transient dominant selection. Of the eight mutant viruses (vA20-1, -2, -3, -5, -ER5, -6, -7, and
-8) generated using this procedure, two (tsA20-ER5 and tsA20-6) exhibited temperature-sensitive phenotypes. We were unable to isolate viruses
containing mutant alleles 4 or ER, suggesting that these mutations might be lethal and unable to support virus viability.
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wt vaccinia virus at a multiplicity of infection (MOI) of 0.03 PFU/cell at 37°C. At
3 h postinfection (hpi), cells were transfected individually with 5 g of a pUC/
neo-A20 mutant construct by using the Lipofectamine Plus reagent and were
shifted to 31.5°C. To select for neomycin-resistant virus generated by plasmid
incorporation, Geneticin (G418) was added to the cells at 18 hpi to a final
concentration of 3 mg/ml. Transfectants were harvested at 48 hpi, and neomycin-
resistant viruses were isolated by two sequential rounds of plaque purification in
the presence of G418. Plasmid integration was confirmed by PCR amplification
of the neo gene. Subsequent plaque purifications were performed in the absence
of G418 so that resolution of the tandemly duplicated A20 alleles, with the
accompanying loss of the intervening neo gene, could occur. Loss of neo was
confirmed by PCR. Determination of which plaques lacking neo retained the wt
A20 allele and which had acquired the mutant A20 allele was accomplished by
amplification and DNA sequence analysis of the A20 locus. Plaques identified as
lacking neo and containing the mutant sequence were subjected to subsequent
rounds of plaque purification until all progeny plaques lacked neo and contained
the mutant A20 allele. These plaques were then expanded, and viral stocks were
prepared. All rounds of infection were performed at 31.5°C.
Determination of 24-h viral yields. Confluent BCS40 cells were infected with
either wt virus, tsA20-6, tsA20-ER5, vA20-1, vA20-2, vA20-3, vA20-5, vA20-7, or
vA20-8 at an MOI of 5 and incubated at either 31.5 or 40°C. At 24 hpi, infected
cells were harvested by scraping, collected by sedimentation, and resuspended in
a constant volume of 10 mM Tris, pH 9.0. Cells were disrupted by three cycles of
freeze-thawing and two 15-s bursts of sonication. Viral yields were then deter-
mined by plaque assays performed at 31.5°C.
Analysis of viral protein synthesis by metabolic labeling. Confluent 35-mm
plates of BSC40 cells were infected with wt virus or tsA20-6 at an MOI of 10 at
either 31.5 or 40°C. At the indicated times postinfection (2, 4, 6.5, and 8.5 hpi),
cells were rinsed with prewarmed methionine-free DMEM and then incubated
with the same medium containing 100 Ci of [35S]methionine/ml. After 45 min,
the cells were harvested by scraping, collected by sedimentation, and resus-
pended in an equal volume of phosphate-buffered saline (PBS, comprising 140
mM NaCl, 2 mM KCl, 10 mM Na2HPO4, 1 mM KH2PO4 [pH 7.4]). Protein
sample buffer (final concentrations, 1% sodium dodecyl sulfate [SDS], 1%
-mercaptoethanol, 10% glycerol, 25 mM Tris [pH 6.8]) was added to an equiv-
alent aliquot of each sample, and cells were thoroughly disrupted by heating at
100°C. Proteins were resolved by electrophoresis on an SDS–10% polyacryl-
amide gel, and radiolabeled proteins were visualized by autoradiography.
Quantitation of viral DNA accumulation. Dishes (diameter, 35 mm) of BSC40
cells were infected with either wt virus, tsA20-6, or tsA20-ER5 at an MOI of 5
and were maintained at 31.5 or 40°C. At 3, 6, 9, 12, and 24 hpi, cells were
harvested by scraping, collected by sedimentation, washed once with PBS, and
resuspended in 300 l of loading buffer (10	 SSC [1	 SSC is 0.15 M NaCl plus
0.015 M sodium citrate]–1 M ammonium acetate). Cells were then disrupted by
three cycles of freeze-thawing. Lysates were diluted with an additional 450 l of
loading buffer, and a 25-l aliquot of each sample was applied, in duplicate, to
a Zeta probe membrane using a Bio-Dot microfiltration apparatus (both from
Bio-Rad, Richmond, Calif.). Samples were denatured (with 1.5 M NaCl and 0.5
M NaOH) and washed twice (with 10	 SSC) in situ. The membrane was then
hybridized with a 32P-labeled nick-translated probe representing the HindIII E
and F fragments of the vaccinia virus genome. After the membrane was washed
and air dried, it was exposed to a phosphor screen overnight and data were
acquired using the Storm PhosphorImager (Molecular Dynamics, Sunnyvale,
Calif.). The data were then quantitated using ImageQuant software (Molecular
Dynamics) and plotted using SigmaPlot (SSPS, Chicago, Ill.) software.
Determination of [3H]thymidine incorporation in tsA20-infected cells. BSC40
cells were infected with either wt virus, tsA20-6, or tsA20-ER5 at an MOI of 5
and were maintained at either 31.5 or 40°C. At the indicated times postinfection
(1.5, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 7, and 8 hpi), cells were rinsed with serum-free
DMEM and then incubated with DMEM containing 10 Ci of [methyl-3H]thy-
midine/ml (83.7 Ci/mmol). After 30 min of labeling, the medium was removed
and cells were rinsed with PBS and then treated in situ with ice-cold NP-40 lysis
buffer (150 mM NaCl, 20 mM Tris [pH 7.8], 1.5 mM MgCl2, 0.65% NP-40). This
treatment disrupts the plasma membrane but leaves the nuclei intact and adher-
ent to the tissue culture dish. The lysis buffer was gently removed from the dish,
and the cytoplasmic nucleic acids were precipitated by adding cold trichloroace-
tic acid (TCA) to 10%. Precipitates were collected on GF/C glass fiber filters
(Whatman, Inc., Maidstone, Kent, England) and washed extensively with ice-
cold 10% TCA. [3H]thymidine incorporation was determined by scintillation
counting after the addition of Ready Protein liquid scintillation cocktail (Beck-
man Coulter, Fullerton, Calif.).
Determination of steady-state levels of the E9 polymerase and the A20 protein.
Confluent 35-mm dishes of BSC40 cells were infected with either wt virus,
tsA20-6, or tsA20-ER5 at an MOI of 5. At 2, 4, and 8 hpi, cells were harvested
by scraping and collected by sedimentation. Cells were washed once with PBS,
resuspended in 1 mM Tris (pH 9.0), and disrupted by three cycles of freeze-
thawing. Extracts were then fractionated on an SDS–10% polyacrylamide gel
electrophoresis (PAGE) gel, and proteins were transferred electrophoretically to
nitrocellulose filters (Schleicher & Schuell, Keene, N.H.). The blot was incubated
with polyclonal sera directed against the A20 protein (24) or the E9 polymerase
(28) (primary sera used at a 1:500 dilution) and subsequently with a horseradish
peroxidase-conjugated goat anti-rabbit secondary antibody (1:15,000 to 1:20,000)
(Bio-Rad). Immunoreactive proteins were visualized by chemiluminescence us-
ing the Pierce (Rockford, Ill.) Super Signal reagents.
Preparation of vaccinia virus cell extracts for in vitro replication assays.
BSC40 cells and mouse L cells were infected with either wt virus, ts42 (E9
polymerase mutant), tsA20-6, tsA20-ER5, ts17 (D5 NTPase mutant), or ts2 (B1
kinase mutant) at an MOI of 15 PFU/cell and were maintained at either 31.5 or
40°C. Hydroxyurea (10 mM) was added to the medium when the inoculum was
removed at 30 min postadsorption and was present until the cells were harvested
at 6 hpi. Cells were scraped, collected via sedimentation, washed in isotonic
buffer (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 5 mM EDTA), and incubated
in hypotonic buffer (10 mM Tris [pH 8.0], 10 mM KCl, 5 mM EDTA) for 10 min.
Cells were then broken open with a Dounce homogenizer, and lysates were
sedimented at low speed to remove nuclei and unbroken cells. The extract was
further clarified by a second sedimentation at 16,000 	 g for 20 min at 4°C.
Glycerol was added to 12%, and aliquots were stored at 80°C until use.
Singly primed M13 replication assay. A primed template was constructed as
described previously (31). Briefly, a 24-mer oligonucleotide primer (5 CGCCA
GGGTTTTCCCAGTCACGAC 3) was annealed to ssM13mp18 at a 20:1 molar
ratio. Extracts prepared from cells infected with either wt virus or ts42, tsA20-6,
tsA20-ER5, ts17, or ts2 at the permissive or nonpermissive temperature were
prepared as described above. These extracts were then assayed for processive
DNA polymerase activity in reaction mixtures containing 10 mM Tris-Cl (pH
7.5), 40 mg of bovine serum albumin/ml, 4% glycerol, 0.1 mM EDTA, 5 mM
dithiothreitol, 8 mM MgCl2, 25 fmol of primed M13 DNA, 750 ng of E. coli SSB,
60 M (each) dCTP, dGTP, and dATP, and 20 M [-32P]TTP (5 Ci/nmol).
Reaction mixtures were preincubated with two of the four dNTPs (dCTP and
dGTP) for 3 min at 30°C, and primer extension was initiated by addition of the
remaining two dNTPs. Reaction mixtures were then incubated for 15 min, and
reactions were stopped by addition of an equal volume of 1% SDS–40 mM
EDTA. Primer extension products were fractionated on a 0.8% agarose gel
containing 0.125 g of ethidium bromide/ml; the gel was cast and run in 1	 TBE
(50 mM Tris, 50 mM boric acid, 1 mM EDTA). The agarose gel was then dried
and exposed to Kodak MR film (Eastman Kodak, Rochester, N.Y.) for autora-
diography.
Computer analysis. Autoradiographic films were scanned with a SAPHIR
scanner (Linotype Hell Co, Hauppauge, N.Y.) and adjusted using Adobe Pho-
toshop (Adobe Systems, Inc., San Jose, Calif.) or Canvas 6.0 (Deneba Systems,
Miami, Fla.) software. Plaque assay results were photographed using an Al-
phaImager (Alpha Innotech, San Leandro, Calif.) digital camera. Figures were
labeled using Canvas 6.0 and printed using a Kodak 8670 dye sublimation
printer.
RESULTS
To conduct a genetic analysis of how the A20 protein func-
tions in the viral life cycle, we chose to generate altered alleles
of A20 by clustered charge-to-alanine mutagenesis. This tech-
nique has been used successfully in our laboratory and in those
of others to generate ts mutants of vaccinia virus and gain
insight into gene function (11, 20, 21). The experimental ra-
tionale is that clusters of charged residues are apt to lie on the
surface of the protein. Therefore, substitutions in these regions
are likely to modulate such properties as protein-protein or
protein-DNA interactions rather than to disrupt global protein
folding. Our goal was to isolate viruses in which the endoge-
nous allele of A20 had been replaced with a mutant allele that
conferred a conditionally lethal phenotype.
Clustered charge-to-alanine mutagenesis of the vaccinia vi-
rus A20 gene: insertion of the altered alleles into the endoge-
nous A20 locus by transient dominant selection. We selected
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multiple regions of the vaccinia virus protein (Fig. 1) for
mutagenesis, based on the presence of clusters of charged
residues. Using overlap PCR, we generated constructs of the
A19- A20-A21 region into which the nucleotides necessary to
encode alanine substitutions had been introduced. We then
utilized transient dominant selection to isolate viruses in which
the mutant A20 allele had replaced the endogenous allele (18).
Briefly, the mutant alleles were cloned into the pUC/neo plas-
mid, which contains the neomycin resistance gene under the
control of a constitutive vaccinia virus promoter (26). Cells
infected with wt virus were transfected with these plasmids and
maintained at 31.5°C in the presence of G418. To select for
viruses in which the plasmid had become incorporated into the
genome, two rounds of plaque purification were performed in
the presence of G418. In these viruses, the drug resistance
gene is flanked by the endogenous and exogenous A20 alleles.
Upon removal of G418 selection, the inherently unstable tan-
dem duplication can resolve, and recombination occurs be-
tween the two A20 alleles. This recombinational resolution
leads to the excision of the neo gene and the retention of either
the wt or the mutant copy of the A20 gene. Loss of the neo
gene was analyzed by PCR, and those plaques that had in fact
retained only the desired mutant allele of A20 were identified
by DNA sequence analysis.
We attempted to generate 10 mutant viruses using the pro-
cedure described above. vA20-1, -2, -3, -ER5, -5, -6, -7, and -8
were isolated and found to be viable at 31.5°C. We were unable
to isolate viruses containing targeted mutations in region 4 or
in the ER region adjacent to region 5. In each of these two
cases, we analyzed more than 20 resolved progeny generated
from multiple neo parental viruses; all were found to be wt at
the A20 locus. We concluded that the particular mutations
generated in these regions of the A20 protein are lethal to the
virus at 31.5°C.
vA20-ER5 and vA20-6 are temperature sensitive as deter-
mined by plaque assay and single-step growth experiments.
The eight mutants isolated were further characterized and
tested for a ts phenotype. First, the viral stocks were titrated in
parallel at 31.5 and 40°C. Two mutants, vA20-ER5, in which
residues 185 to 191 were changed from ERSFDDK to AAS-
FAAA (mutated nucleotides are boldfaced), and vA20-6, in
which residues 265 to 269 were changed from KVKKK to
AVAAA, were found to be temperature sensitive. Both mutants
were unable to form plaques at 40°C but formed plaques of
normal size when titrations were performed at 31.5°C (Fig. 2).
These two mutants were henceforth designated tsA20-ER5
and tsA20-6. The plaques formed by the other mutants were
comparable to those seen with wt virus at both temperatures
(data not shown).
Second, single-step growth experiments were performed
with all of the mutants isolated. Confluent monolayers of
BSC40 cells were infected at both 31.5 and 40°C (at an MOI of
5), and the 24-h viral yield from this single round of infection
was then quantitated (Fig. 3). Cells infected with tsA20-6 at
40°C produced 2 orders of magnitude less virus than parallel
cultures maintained at 31.5°C; a comparable result was ob-
tained from infections performed in L cells (data not shown).
tsA20-ER5-infected cultures showed a 2.5-log-unit decrease in
yield at 40°C relative to the yield obtained at 31.5°C. wt-in-
fected cultures, and those infected with the viruses containing
the other mutant A20 alleles, produced comparable yields of
virus at both temperatures. Thus, the A20-1, -2, -3, -5, -7, and
-8 mutations appeared to have no impact on the infectious
cycle, and the viruses containing these alleles were therefore
not subjected to further analysis.
The data described above indicated that mutation of the A20
locus could have a profound impact on the ability of vaccinia
FIG. 2. tsA20-ER5 and tsA20-6 do not form plaques at the non-
permissive temperature. Equivalent numbers of PFU of wt virus,
tsA20-ER5, or tsA20-6 were used to infect confluent 60-mm dishes of
BSC40 cells. Cells were maintained at either 31.5 or 40°C for 48 h,
after which plates were stained with crystal violet and compared for
plaque formation.
FIG. 3. tsA20-6 and tsA20-ER5 show a temperature-sensitive de-
fect in the production of infectious virus from a single round of infec-
tion. Confluent dishes of BSC40 cells were infected with either wt
virus, vA20-1, vA20-2, vA20-3, vA20-5, tsA20-ER5, tsA20-6, vA20-7, or
vA20-8 at an MOI of 5 and were maintained at either 31.5 or 40°C for
24 h. Cells were then harvested, and the viral yield was determined in
plaque assays performed at 31.5°C.
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virus to mediate a productive infection. Confirmation that the
temperature sensitivity exhibited upon acquisition of the A20-6
allele was indeed linked to this allele was obtained from
marker rescue studies. Briefly, transfection of a plasmid en-
coding the wt A20 allele (but not the corresponding vector
alone) could “rescue” the ts phenotype by recombination with
the tsA20-6 genome (data not shown). These data confirmed
that the phenotype of tsA20-6 is due to the altered A20 allele
and not to any other changes within the viral genome. Coin-
fections with wt virus were also performed, and quantitation of
the viral yield indicated that both tsA20 alleles have a recessive
phenotype (data not shown). Taken together, the data in Fig.
2 and 3 indicate that the protein encoded by the vaccinia virus
A20 gene plays an essential role in the viral life cycle.
tsA20-6-infected cells fail to synthesize late viral proteins at
the nonpermissive temperature. Both tsA20-6 and tsA20-ER5
show a profound temperature sensitivity that causes a severe
arrest in the infectious cycle. To determine which stage of the
vaccinia virus life cycle was affected in these ts mutants, we first
examined the temporal profile of protein synthesis in cells
infected with wt virus or tsA20-6 at the permissive and non-
permissive temperatures. After infection at an MOI of 10,
BSC40 cells were metabolically labeled with [35S]methionine
for 45 min at various times postinfection; total cell lysates were
then resolved by SDS-PAGE and visualized by autoradiogra-
phy (Fig. 4). The expression pattern seen in cells infected with
tsA20-6 at the permissive temperature is virtually identical to
that seen in wt-infected cells (Fig. 4; compare lanes 12 to 15
with lanes 2 to 5). However, a clear defect is seen in cells
infected with tsA20-6 at the nonpermissive temperature. Al-
though the expression of early proteins appears to be normal
(Fig. 4; compare lanes 17 to 20 [tsA20-6] to lanes 7 to 10 [wt]),
late viral proteins are not expressed (compare lanes 19 and 20
with lanes 8 to 10, 14, and 15). Thus, at the nonpermissive
temperature, tsA20-6 is apparently able to enter cells and di-
rect the expression of early mRNAs and proteins. However,
the life cycle arrests prior to the expression of late genes. This
arrest could reflect a defect in secondary uncoating, DNA
replication, or intermediate or late gene expression.
DNA replication is severely impaired in tsA20-ER5- and
tsA20-6-infected cells. To establish if the block in tsA20-6 and
tsA20-ER5 infections occurs at the stage of DNA replication,
the accumulation of viral genomes during the infectious cycle
was quantitated. Cells were infected with either wt virus,
tsA20-ER5, or tsA20-6 and maintained at either 31.5 or 40°C.
At 3, 6, 9, 12, and 24 hpi, cells were harvested and aliquots of
total cellular extracts were subjected to DNA dot blot hybrid-
ization analysis. Data were quantitated on a phosphorimager
and are shown graphically in Fig. 5. When cells were infected
with wt virus, the profile of viral DNA accumulation was sim-
ilar at both temperatures, with somewhat more DNA being
accumulated at 40°C (Fig. 5A). At 9, 12, and 24 hpi, levels of
DNA accumulated at 40°C relative to those at 31.5°C were 186,
139, and 137%, respectively. This was not true in cells infected
FIG. 4. Synthesis of late viral proteins is abolished during nonpermissive infections performed with tsA20-6. Confluent 35-mm dishes of BSC40
cells were infected with either wt virus or tsA20-6 at an MOI of 10 and maintained at either 31.5 or 40°C. Cells were metabolically labeled with
[35S]Met for 45 min prior to being harvested at the times indicated. Uninfected cells (u) were analyzed in parallel at both temperatures. Cell
extracts were fractionated on an SDS–10% PAGE gel, and the nascent polypeptides were visualized by autoradiography. Ovals and stars represent
characteristic early and late viral proteins, respectively. Circles indicate the late proteins that are absent in lanes 19 and 20. The arrowhead indicates
a cellular protein whose synthesis declines during vaccinia virus infections.
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with tsA20-ER5 or tsA20-6. At the permissive temperature, the
profile seen after tsA20-ER5 infection was similar to that ob-
served with wt virus (Fig. 5C): DNA accumulation increased
after 3 hpi and began to level off after 12 hpi. In tsA20-6-
infected cells, DNA accumulation was not seen until 6 hpi and
continued without leveling off for the duration of the 24-h
infection (Fig. 5B). Most importantly, cells infected at 40°C
with either ts mutant showed a severe impairment in the ac-
cumulation of viral DNA (Fig. 5B and C). At 24 hpi, the ratio
of DNA accumulation in cells infected with tsA20-6 at 40°C to
that in cells infected at 31.5°C was 17%; in cells infected with
tsA20-ER5 this ratio was 7%. These data provide compelling
evidence that the lesions in the tsA20 viruses compromise viral
DNA replication.
To confirm that the defect is indeed intrinsic to DNA rep-
lication and does not affect the prerequisite stage of secondary
uncoating, we performed shift-experiments. Infections were
allowed to initiate at 31.5°C and were then shifted to 40°C at 6
hpi, a point at which the infectious cycle has progressed past
uncoating and DNA replication has already begun. Indeed, as
shown in Fig. 4 (lane 14), late gene expression is already robust
at this time in cells infected with tsA20-6 at 31.5°C. We exam-
ined the accumulation of viral DNA at 7, 8, and 9 hpi in these
shifted cultures (Fig. 5B and C). In both tsA20-6- and tsA20-
ER5-infected cells, further DNA accumulation was curtailed,
indicating that the mutations have a direct impact on DNA
replication. In cells infected with tsA20-6, in which little DNA
has accumulated by 6 hpi, the levels of viral DNA seen at 7, 8,
and 9 hpi in the shifted cultures paralleled those seen in cells
maintained at 40°C for the entire experiment. In cells infected
with tsA20-ER5, there appeared to be a 1-h lag during which
replication continued after the shift to the nonpermissive tem-
perature; after 7 hpi, however, no additional viral DNA accu-
mulated.
To investigate the block in DNA replication in more detail,
we examined the early stages of viral DNA replication by
monitoring the incorporation of [3H]thymidine in tsA20-6- and
tsA20-ER5-infected cells. Cells were infected with the ts mu-
tants and either maintained at 31.5 or 40°C or shifted from 31.5
to 40°C at 3.5 or 4 hpi. The incorporation of [3H]thymidine
into cytoplasmic nucleic acids during sequential 30-min periods
of pulse-labeling was then determined. For tsA20-6-infections
maintained at 31.5°C, thymidine incorporation showed a broad
peak from 3.5 to 5.5 hpi and then declined (Fig. 6A). For
tsA20-ER5 infections, a narrower peak of thymidine incorpo-
ration occurred between 4 and 5 hpi (Fig. 6B). This general
profile of thymidine incorporation is similar to what has been
reported by us and others for wt-infected cells (17, 32, 35); the
decline in thymidine incorporation at a time when DNA rep-
lication continues at a robust rate is attributed to feedback
inhibition of the viral thymidine kinase as well as changes in
the intracellular nucleotide pools (22, 40). Both ts mutants
showed impaired thymidine incorporation at the nonpermis-
sive temperature. These data support our conclusion that these
ts mutants are defective in DNA replication. When cultures
were infected with tsA20-6 at 31.5°C and then shifted to 40°C,
thymidine incorporation began to decline 30 min after the
cultures were shifted and had dropped to the levels seen with
the 40°C-only cultures by 60 to 90 min postshift. In tsA20-ER5-
infected cultures, a decrease in thymidine incorporation was
seen immediately after the shift, and incorporation was re-
duced to that seen in the 40°C-only cultures by 60 min post-
shift. These data confirm that both of the tsA20 mutants have
profound defects in viral DNA replication.
Both the A20 and polymerase proteins accumulate normally
during nonpermissive tsA20 infections in BSC40 cells. Having
established that defects in the A20 protein cause a DNA
phenotype, we were interested in determining what aspect(s)
FIG. 5. DNA replication is defective at the nonpermissive temperature in cells infected with tsA20-ER5 or tsA20-6. Confluent monolayers of
BSC40 cells were infected with either wt virus (A), tsA20-6 (B), or tsA20-ER5 (C) and maintained at 31.5°C (dashed line) or 40°C (solid line). In
some cases, cells were infected at 31.5°C and then shifted to 40°C at 6 hpi (dotted line). At the indicated time points, cells were harvested and lysed,
and equivalent amounts of sample were spotted in duplicate onto a Zeta probe membrane. Accumulation of viral DNA was monitored by dot blot
hybridization using a radiolabeled nick-translated probe representing the HindIII E and F fragments of the vaccinia virus genome. Signals were
quantitated using a Storm PhosphorImager, and a graphic representation was prepared using SigmaPlot software.
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of A20’s functioning was impaired in these ts alleles. To inves-
tigate whether the proteins encoded by the tsA20-6 and tsA20-
ER5 alleles were thermolabile, we prepared extracts from
BSC40 cells at 2, 4, and 8 h after infection with either wt virus,
tsA20-6, or tsA20-ER5 at the permissive or nonpermissive tem-
perature. Aliquots were resolved by SDS-PAGE, transferred
to nitrocellulose filters, and probed with the anti-A20 serum
(Fig. 7). The temporal profiles of A20 accumulation were com-
parable in all of the infections, indicating that the A20 proteins
encoded by the ts alleles are not thermolabile. The A20 protein
was first detected at 4 hpi at 31.5°C and at 2 hpi at 40°C.
Interestingly, the A20 proteins encoded by the two mutant
alleles had slightly faster electrophoretic mobilities than the wt
protein (Fig. 7A; compare 4- and 8-hpi lanes for wt virus,
tsA20-6, and tsA20-ER5). We were also interested in deter-
mining whether the lesions in the A20 protein might cause
destabilization of the E9 DNA polymerase, which could in turn
compromise DNA replication. The upper half of the same blot
was therefore probed with the anti-DNA polymerase antibody.
The levels of polymerase at the nonpermissive and permissive
temperatures were equivalent in cells infected with wt virus or
with either of the ts mutants. Since neither the level of the A20
FIG. 6. [3H]thymidine incorporation is impaired in cells infected with tsA20-ER5 and tsA20-6 at the nonpermissive temperature. Cells were
infected with either tsA20-6 (A) or tsA20-ER5 (B) and incubated at either 31.5 or 40°C. In some cases, infection was initiated at 31.5°C and then
cultures were shifted to 40°C at 3.5 or 4 hpi. At various times postinfection, cells were incubated for 30 min with DMEM containing 10 Ci of
[methyl-3H]thymidine/ml prior to being harvested under conditions which leave the nuclei intact and adherent to the culture dish. Cytoplasmic
nucleic acids were concentrated by acid precipitation and immobilized on glass fiber filters. [3H]thymidine incorporation was quantitated by liquid
scintillation counting. Data shown in panels A and B were obtained in independent assays; therefore, the use of different scales on the ordinate
is not significant.
FIG. 7. The A20 and E9 (polymerase) proteins accumulate to normal levels during nonpermissive infections with tsA20-ER5 and tsA20-6. Cells
were infected with either wt virus, tsA20-ER5, or tsA20-6 at an MOI of 5 and were incubated at either 31.5 or 40°C. At the indicated times
postinfection, cells were harvested and disrupted by three cycles of freeze-thawing. Aliquots of the extracts were fractionated on an SDS–10%
PAGE gel and transferred to a nitrocellulose filter. The filter was cut in half at the 68-kDa marker; the top half of the blot was probed with a
polyclonal anti-DNA polymerase (-Pol) serum, and the bottom half was probed with a polyclonal anti-A20 serum.
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protein nor that of the DNA polymerase was affected in non-
permissive tsA20-6 and tsA20-ER5 infections, the defect in
these infections appears to be at the level of protein function
rather than at the level of synthesis or stability.
Extracts prepared from cells infected with tsA20-6 or tsA20-
ER5 do not direct the processive conversion of singly primed
M13 DNA to the RFII form. There is, as yet, no in vitro system
for poxvirus DNA replication. Nor are assays available to dis-
sect replication in vivo, beyond the ability to monitor [3H]thy-
midine incorporation, accumulation of viral DNA, and resolu-
tion of replication intermediates into monomeric genomes. We
have, however, previously described the ability of cytoplasmic
extracts of wt-infected cells to direct processive DNA synthesis
on a singly primed M13 template in vitro (29). This assay was
the basis of our conclusion that processive synthesis required
both the E9 polymerase and at least one other early viral
protein. Activity was abolished when cells were infected with a
mutant encoding a temperature-sensitive DNA polymerase
(ts42). Recombinant polymerase, however, could be used to
reconstitute processive activity when added back to these poly-
merase-deficient extracts but not when added to similarly pre-
pared extracts of uninfected cells. The accompanying paper
(24) demonstrates that extracts prepared from cells overex-
pressing both the A20 protein and DNA polymerase show a
significant increase in processive polymerase activity over that
in extracts from cells in which only the polymerase is overex-
pressed. These data provide provocative evidence that A20 and
DNA polymerase together might constitute the processive en-
zyme.
As an alternative approach to analyzing the role of A20 in
the generation of processive polymerase activity, we examined
the abilities of cytoplasmic extracts of cells infected with
tsA20-6 or tsA20-ER5 to form RFII in the same in vitro assay.
BSC40 cells or mouse L cells were infected with either wt virus,
ts42 (DNA polymerase mutant), tsA20-6, tsA20-ER5, ts17 (D5
NTPase mutant), or ts2 (B1 kinase mutant) and maintained at
either the permissive or the nonpermissive temperature. Cyto-
plasmic extracts were prepared from these infected cells as
described in Materials and Methods, and these extracts were
then tested for the ability to direct RFII formation using a
singly primed M13 template in vitro. After a 3-min preincuba-
tion reaction that allowed replication complexes to assemble at
the primer-template junction, synchronous DNA synthesis was
initiated and allowed to proceed for 15 min at 30°C. These
reactions were performed in the presence of 8 mM MgCl2,
under which conditions the free E9 polymerase is highly dis-
tributive and is unable to copy the 
7-kB template in the time
allotted (31). Reaction products were fractionated on a TBE-
agarose gel and visualized by autoradiography. Results are
shown in the upper panels of Fig. 8; both the short products
generated during distributive synthesis and the full-length
RFII product generated during processive synthesis are indi-
cated. Consistent with previous results (29), extracts prepared
from BSC40 or L cells infected with ts42 (E9 polymerase mu-
tant) at either the permissive or nonpermissive temperature
failed to catalyze RFII formation (Fig. 8, lanes 3 and 4). The
polymerase encoded by this mutant is extremely thermolabile,
and no active enzyme can be detected in vitro (28). Even the
short products diagnostic of distributive synthesis are absent in
these reactions. Of significant importance to the present work
is the observation that extracts prepared from BSC40 or L cells
infected with tsA20-6 or tsA20-ER5 also failed to form RFII
(Fig. 8, lanes 5 to 8). This defect was seen with extracts pre-
pared from cells infected at either temperature and indicates
that cells infected with these A20 mutants produce no proces-
sive polymerase activity that can be assayed in vitro. It is worth
noting that the short products generated by the free polymer-
ase acting in a distributive mode are present in these reactions.
The experiment for which results are shown in Fig. 7 indi-
cated that the A20 proteins encoded by tsA20-6 and tsA20-
ER5 were not thermolabile and accumulated to wt levels dur-
ing nonpermissive infections performed in BSC40 cells. We
wanted to confirm that the inability of the cytoplasmic lysates
prepared from tsA20-infected cells to direct processive RFII
formation was not due, however, to the absence of soluble
DNA polymerase or A20 protein in these lysates. Therefore,
the cytoplasmic lysates prepared from both the BSC40 and L
cells were resolved by SDS-PAGE and transferred to a nitro-
cellulose filter. The top half of the filter was developed with an
anti-DNA polymerase serum, and the bottom half was devel-
oped with an anti-A20 serum. Results are shown in the lower
panels of Fig. 8; the immunoblots are aligned with the auto-
radiograph illustrating RFII formation. Both the DNA poly-
merase and the A20 protein were present at wt levels in lysates
prepared from BSC40 or L cells infected with tsA20-6 or
tsA20-ER5 at 31.5°C (Fig. 8; compare lanes 5 and 7 with lanes
1 and 2 in both panels). Therefore, the absence of processive
polymerase activity in these lysates cannot reflect a loss of the
A20 and polymerase proteins per se but rather reflects their
inability to collaborate in forming RFII. When lysates were
prepared from BSC40 cells infected at 40°C with tsA20-6,
equivalent levels of the DNA polymerase and A20 appeared to
be present (Fig. 8A, lane 6). There was a specific diminution,
however, in the levels of A20 seen in some cultures infected at
40°C: BSC40 cells infected with tsA20-ER5 (Fig. 8A, lane 8)
and L cells infected with tsA20-ER5 or tsA20-6 (Fig. 8B, lanes
6 and 8). As expected, polymerase was significantly depleted in
extracts prepared from ts42-infected cells (Fig. 8, lanes 3 and
4); a corresponding diminution in the levels of A20 was also
observed. The latter was unexpected and suggests that A20
might be either unstable or less soluble in the presence of the
defective ts42-encoded DNA polymerase.
The defect in RFII formation seen with extracts prepared
from tsA20-infected cells provides strong evidence that muta-
tion of A20 causes a specific defect in processive DNA poly-
merase activity. This in vitro reaction asks for nothing more
complex than processive DNA synthesis: a free primer termi-
nus is provided, and the template is single-stranded and kept
free of secondary structure by the inclusion of E. coli SSB.
Thus, auxiliary functions that might be involved in initiation or
template unwinding are not required. The specificity of the
defect seen with ts42, tsA20-ER5, and tsA20-6 is underscored
by the results obtained with ts mutants carrying lesions in the
D5 DNA-independent NTPase (ts17) (15–17, 35) or the B1
protein kinase (ts2) (33, 34). Extracts from BSC40 cells in-
fected with ts17 or ts2 at either the permissive or nonpermissive
temperature are able to catalyze RFII formation in vitro (Fig.
8A, lanes 9 to 12). Thus, although these mutants exhibit a ts
DNA phenotype in vivo, their defect is not manifested in
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vitro in this specific assay, which demands only the ability to
elongate a primer in a processive fashion.
DISCUSSION
Using a biochemical approach, we identified the vaccinia
virus A20 protein as a stoichiometric component of the pro-
cessive form of the viral DNA polymerase (24). In this report,
we undertook a complementary genetic analysis of A20 in
order to better understand its structure and function in the
viral life cycle. Using clustered charge-to-alanine mutagenesis,
we generated 10 altered alleles of the A20 gene and attempted
to isolate viruses containing each of these alleles in place of the
endogenous A20 gene. We were successful in isolating eight
such viruses (vA20-1, -2, -3, -5, -ER5, -6, -7, and -8). We were
unable to isolate vA20-4 or vA20-ER and feel justified in
concluding that these alleles are not competent to support a
productive infectious cycle. Six of the other alleles (A20-1, -2,
-3, -5, -7, and -8) supported virus viability and did not confer
any apparent phenotype. Two alleles (A20-ER5 and A20-6),
however, engendered profound temperature-sensitivity.
Since the sequence of the A20 gene does not show any
significant homology to genes other than the orthologs found
in other poxviruses, and since it does not contain any recog-
nizable motifs, it was difficult to predict which mutations might
alter the protein in a way that would perturb its function in
vivo. One of the alleles that appeared to be lethal to the virus,
A20-4 (177DDE1793AAA), affects a region that is somewhat
conserved among chordopoxvirus genomes; these three
charged residues are flanked by two invariant aromatic resi-
dues. It was also of interest to see that whereas the A20-ER
allele (185ERSFDDK1913AASFDDK) appeared to be incom-
patible with virus viability, and the adjacent A20-5 allele
(185ERSFAAA191) conferred no phenotype in vivo, the two in
combination (A20-ER5) (185AASFAAA191) conferred a tem-
perature-sensitive phenotype. This region is not highly con-
served in the A20 homologs encoded by diverse poxviruses (see
reference 24) (Fig. 2A), but the presence of charged residues
FIG. 8. Extracts prepared from cells infected with tsA20-ER5 or tsA20-6 cannot direct the processive synthesis of RFII in a singly primed M13
replication assay. BSC40 cells (A) and mouse L cells (B) were infected at an MOI of 15 with wt virus (lanes 1 and 2), tsE9 (lanes 3 and 4), tsA20-6
(lanes 5 and 6), tsA20-ER5 (lanes 7 and 8), tsD5 (lanes 9 and 10), or tsB1 (lanes 11 and 12) and maintained at 31.5°C (lanes 1, 3, 5, 7, 9, and 11)
or 40°C (lanes 2, 4, 6, 8,10, and 12). At 6 hpi, infected cells were harvested, and cytoplasmic extracts were prepared as described in Materials and
Methods. These extracts (2.0 g) were then assayed in reaction mixtures containing 25 fmol of primed M13 ssDNA, 750 ng of E. coli SSB, 60 M
(each) dATP, dGTP, and dCTP, 20 M [-32P]TTP, and 8 mM MgCl2. After 15 min of incubation at 30°C, the reactions were stopped, and DNA
products were fractionated on a 0.8% TBE-agarose gel containing ethidium bromide and visualized by autoradiography. The arrow indicates the
RFII product; the bracket indicates the short DNA products that result from distributive polymerase activity. Aliquots of the same extracts were
also subjected to immunoblot analysis with antisera directed against the DNA polymerase (-POL) or A20 protein (-A20). The immunoblot is
aligned underneath the corresponding samples of the autoradiograph illustrating RFII formation.
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at the position corresponding to 185ER186 is frequent. In es-
sence, the A20-5 allele serves as a partial intragenic suppressor
of the ER allele. The other allele that conferred a tempera-
ture-sensitive phenotype, A20-6 (265KVKKK2693AVAAA),
affects a region that is fairly well conserved in the various
poxvirus homologs. Both of the ts alleles encode proteins that
are stable in vivo, which is unusual; in our experience, most
proteins encoded by ts alleles are thermolabile.
Generation of two viruses in which mutation of the A20
allele conferred a dramatic temperature-sensitive phenotype
allowed us to probe the role of this protein in the viral life
cycle. At the permissive temperature, the infectious cycles di-
rected by these ts viruses were comparable to those observed
with wt virus. At the nonpermissive temperature, plaque for-
mation was abolished and the viral yield produced in a 24-h
infection (at an MOI of 5) was reduced by 2 to 2.5 orders of
magnitude. The viral life cycle appeared to progress normally
through the expression of early proteins but then arrested at
the phase of DNA replication. Dot blot hybridization analysis
of viral DNA accumulation, and quantitation of [3H]thymidine
incorporation, indicated that DNA synthesis was largely abol-
ished at the nonpermissive temperature. We observed a ces-
sation of DNA synthesis when cultures that had been infected
at 31.5°C were shifted to 40°C at a time when replication had
already begun, confirming that the A20 lesions have a direct
impact on ongoing DNA synthesis. They do not, instead, act
indirectly by inhibiting a prerequisite step such as secondary
uncoating. The cessation of synthesis in the shifted cultures
was not immediate, however; a lag of 30 to 60 min was typical.
The presence of this lag was somewhat surprising, since many
mutants with defects in key replication proteins show a fast-
stop phenotype, in which ongoing DNA synthesis ceases im-
mediately when cultures are shifted to the nonpermissive tem-
perature (17). The lag seen with both tsA20-ER5 and tsA20-6
suggests that the mutant A20 proteins might lose function
slowly upon shift to the nonpermissive temperature and/or
might manifest their defect only when a new round of synthesis
begins on a fresh template. The mutant proteins are not ther-
molabile but instead show a functional thermosensitivity; per-
haps A20 undergoes a conformational change or a loss of
function when it dissociates from the template after helping
the polymerase complete synthesis on a given template.
The observation that tsA20-ER5 and tsA20-6 had a pro-
found and specific defect in viral DNA replication was fully
consistent with our purification of A20 as a major component
of the processive DNA polymerase complex. We therefore
reasoned that the DNA phenotype would reflect an inability
of the A20/DNA polymerase complex to direct processive syn-
thesis in vivo and that this deficit would be retained in vitro.
This hypothesis was tested by examining the ability of extracts
prepared from cells infected with tsA20-ER5 or tsA20-6 to
convert a singly primed M13 template to the RFII product in
a processive manner. These extracts were incompetent in this
assay, unlike extracts prepared from wt-infected cells. No RFII
product was seen using the extracts prepared at 31.5 or 40°C.
This constitutive absence of activity is also characteristic of
extracts prepared from cells infected with ts42, a virus with a
lesion in the DNA polymerase gene (29). Presumably, al-
though these mutant proteins retain sufficient function in vivo
at 31.5°C, perhaps due to the stabilizing influence of other viral
proteins or the cytoplasmic architecture, they do not manifest
this function in vitro. This is particularly striking in the case of
the tsA20 extracts, since we have shown that both the A20 and
DNA polymerase proteins are stable and are indeed present
within these extracts. Furthermore, the short products charac-
teristic of distributive polymerase action are formed by the
tsA20 extracts, and we have not observed any defect in the
ability of these extracts to synthesize short stretches of DNA
using an activated salmon sperm template (data not shown)
(30). Thus, the A20-ER5 and A20-6 proteins are unable to
perform some or all of the activities required in the M13 assay.
Because of the relative simplicity of this assay, we presume that
it is the interaction with the polymerase, the interaction with
the DNA template, or a hypothetical interaction(s) with other
modulatory proteins that is affected. Determination of what
facet of its activity as a likely processivity factor is incapacitated
by the lesions in tsA20-ER5 and tsA20-6 will be investigated in
future studies.
During the course of this work, the laboratories of B. Moss
and S. Fields published a yeast two-hybrid analysis of interac-
tions among the full repertoire of vaccinia virus proteins (27).
In this assay, the A20 protein was shown to interact with the
D5 (dNTPase) and D4 (uracil DNA glycosylase) proteins,
which have been shown to play essential roles in viral DNA
replication (40). These observations are provocative and war-
rant further investigation. An interaction with the H5 protein
was also observed. The abundant H5 phosphoprotein appears
to have multiple roles in the viral life cycle. H5 has been shown
to stimulate the transcription of late genes in vitro (25), and
several mutant alleles of H5 confer a dominant, temperature-
sensitive phenotype in vivo and cause an arrest at an early stage
of virion morphogenesis (11). H5 is also a substrate for the B1
protein kinase, which has been shown to be important for viral
DNA replication, and appears to relocate to replication facto-
ries as DNA synthesis begins (1–3). If H5 serves as a scaffold-
ing protein for DNA synthesis, then an interaction with A20
might prove to be important.
Subsequent to this two-hybrid analysis, the Moss laboratory
also undertook a clustered charge-to-alanine mutagenesis of
the A20 gene; their findings, as well as ours, were reported at
the XIIIth International Poxvirus Workshop (Montpellier,
France, September 2000), and their work has already been
published (23). The collections of A20 alleles generated in the
two studies overlap, and our results are in general agreement
with theirs regarding the phenotypes observed. Of note, our
tsA20-ER5 virus corresponds to mutant 185 of Ishii and Moss,
and for those assays performed in common, comparable evi-
dence of a severe ts DNA phenotype was obtained.
In sum, the results presented here and in the accompanying
paper (24) identify the A20 protein as playing an essential role
in vaccinia virus replication. Unraveling how the A20 protein
interacts with DNA, the DNA polymerase, and other modula-
tory viral proteins to accomplish processive and faithful repli-
cation of the genome is of significant interest. These studies
will enhance our understanding of vaccinia virus biology and
should also provide insight into the broader question of how
microorganisms and cells accomplish the universal task of
DNA replication.
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